SCHEMBL4382966

SCHEMBL4382966

CC1=NN(c2ccccc2)C(=O)/C1=C\c1ccc(N)cc1

nearest known ligand 0.76

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.76
L3MBTL1 Q9Y468 7/20 0.76
MEN1 O00255 5/20 0.76
GAA P10253 2/20 0.66
KAT8 Q9H7Z6 1/20 0.64
POLB P06746 2/20 0.64
MAPT P10636 8/20 0.60
ALDH1A1 P00352 6/20 0.60
KDM4E B2RXH2 5/20 0.60
TDP1 Q9NUW8 4/20 0.60
HPGD P15428 2/20 0.60
PKM P14618 1/20 0.60
MAPK1 P28482 6/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
LMNA P02545 2/20 0.58
HTT P42858 2/20 0.58
AMY1A P0DUB6 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16788880 0.90 KMT2A (0.82) KMT2AL3MBTL1MEN1GAAKAT8
SCHEMBL29010258 0.90 KMT2A (0.82) KMT2AL3MBTL1MEN1GAAKAT8
SCHEMBL28473982 0.90 KMT2A (0.82) KMT2AL3MBTL1MEN1GAAKAT8
SCHEMBL28476008 0.90 KMT2A (0.81) KMT2AL3MBTL1MEN1GAAKAT8
SCHEMBL10035997 0.90 KMT2A (0.81) KMT2AL3MBTL1MEN1GAAKAT8
SCHEMBL28967916 0.90 KMT2A (0.81) KMT2AL3MBTL1MEN1GAAKAT8
SCHEMBL446478 0.86 KMT2A (0.76) KMT2AL3MBTL1MEN1GAAKAT8
SCHEMBL13011253 0.86 KMT2A (0.76) KMT2AL3MBTL1MEN1GAAKAT8
SCHEMBL29045580 0.86 AMY1A (0.76) KMT2AL3MBTL1MEN1GAAKAT8
SCHEMBL420808 0.86 KMT2A (0.76) KMT2AL3MBTL1MEN1GAAKAT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629340-B2 N-(6-membered aromatic ring)-amido anti-viral compounds SMITHKLINE BEECHAM CORPORATION (US) 2009-12-08 US disclosed
EP-1976829-A2 N-(6-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS GENELABS TECHNOLOGIES, INC. (US) 2008-10-08 EP disclosed
US-20070265262-A1 N-(6-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS GENELABS TECHNOLOGIES, INC. 2007-11-15 US disclosed
WO-2007070556-A2 N-(6-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS GENELABS TECHNOLOGIES, INC. (US) 2007-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265262-A1 N-(6-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS ZC3HAV1, HAVCR2, ZC3HAV1L KMT2A 2578/4885L3MBTL1 505/4885MEN1 3978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.